Core Laboratories (CLB) Tops Q4 EPS by 3c; Guides Light Q1 EPS, FY12 In-Line
Core Laboratories N.v. (NYSE: CLB) reported Q4 EPS of $1.11, $0.03 better than the analyst estimate of $1.08.
Core Laboratories N.v. sees Q1 2012 EPS of $1.01-$1.06, versus the consensus of $1.08.
Core Laboratories N.v. sees FY2012 EPS of $4.50-$4.82, versus the consensus of $4.67.
For earnings history and earnings-related data on Core Laboratories N.v. (CLB) click here.
Core Laboratories N.v. sees Q1 2012 EPS of $1.01-$1.06, versus the consensus of $1.08.
Core Laboratories N.v. sees FY2012 EPS of $4.50-$4.82, versus the consensus of $4.67.
For earnings history and earnings-related data on Core Laboratories N.v. (CLB) click here.